You are new here, so forgiven. Prior management screwed us over horribly.
Present management nastily grabbed a huge chunk of the company, but now has a big vested interest.
While it's not ideal, it's finally competent and economically committed.
Wrong kvetch bull-shi...
Seeing as ADRO took our patent IP and ran with it before the patents elapsed,
why aren't we in litigation with them?
The settlement might fund a Ph3 trial.
Awkwardly, they are aging out, thanks in part to the previous administration. Otherwise we would not have a competitor .
Meanwhile biotechnology is advancing fast and we are squatting in place.
Our constructs should be FDA approved and on the market curing cancers by now!
When the hold gets lifted, our clinical trials in progress will probably have to restart from scratch,
and that's going to cost us Big Time!.
I wonder if we shouldn't be taking legal action against the FDA?
They should be funding our clinical trials from this point forward.
We should be demanding a congressional investigation into the delay!
Snort, paw the ground!
You had the "Bullsh"part right.
Management is pretty greedy, but at least they are competent.
Guess who pays out the nose when our regulatory agencies are underfunded?
"Excessive politics" cost us profoundly when we elect legislators who are too childish and ego-fat
to realize that a democracy means opposing parties work out a compromise so government continues to function.
Anyone who is certain they are right is a fool!
"Testing " is the operative word here.
In medicine, when you see claims that a single drug candidate cures a number of hitherto unrelated diseases....It's time to get nervous!
Historically, that's been the hallmark of quackery, time and time again.
I'm long and that part bothers me a lot.
Lets wait and see how the clinical trials shake out
before we make any pronouncements, like we were adults.
Some excellent points; but...
1.You advocate charting and trading. That puts you up against the best and smartest folks money can buy, with the best research, financing, computers and connections and inside knowledge and influence we don't have a chance at....Bad odds there.
2.I'd much rather suffer mediocre PPS performance and know that i backed a company that saved lives...By a huge margin.
I'm an old guy and a cancer survivor and i'm watching cancer kill my friends one by one.
Kinda changed my attitude.
I sincerely hope you are right.
But let's let the clinical trials reveal the truth here.
The hyperbole is a bit much.
If we can demonstrate the same results in a much bigger double blind study;
It'll be time to celebrate.
Until then, we wait and hope.
While i'm long here,
Lets keep it real.
History is littered with the dried corpses of promising ALZ drugs that failed Ph 3.
The odds aren't all that good.
This one is a tasty bet, but still a maybe.
That guy has a profoundly ugly soul and i want Nothing to do with him.
He will happily lie for profit regardless of who is hurt and jacked the price of an old generic lifesaving drug unconscionably.